{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:09:38Z","timestamp":1792800578650,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shandong University of Traditional Chinese Medicine 2025 Postgraduate Quality Improvement and Innovation Project","award":["YJSTZCX2025142"],"award-info":[{"award-number":["YJSTZCX2025142"]}],"id":[{"id":"https:\/\/ror.org\/0523y5c19","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Key Research and Development Program of China","award":["2023YFC3606200"],"award-info":[{"award-number":["2023YFC3606200"]}]},{"name":"National Administration of Traditional Chinese Medicine High-Level Key Discipline Construction Project of Traditional Chinese Medicine","award":["zyyzdxk-2023118"],"award-info":[{"award-number":["zyyzdxk-2023118"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-025-02796-z","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T11:41:00Z","timestamp":1763984460000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The association between different lipid indices and hyperuricemia in older adults: a cross-sectional study"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2763-3345","authenticated-orcid":false,"given":"Yingkai","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8021-769X","authenticated-orcid":false,"given":"Yufang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"2796_CR1","doi-asserted-by":"publisher","first-page":"111932","DOI":"10.1016\/j.intimp.2024.111932","volume":"132","author":"S Yang","year":"2024","unstructured":"Yang S, Liu H, Fang XM, Yan F, Zhang Y. Signaling pathways in uric acid homeostasis and gout: from pathogenesis to therapeutic interventions. Int Immunopharmacol. 2024;132:111932.","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"2796_CR2","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1002\/art.40807","volume":"71","author":"M Chen-Xu","year":"2019","unstructured":"Chen-Xu M, Yokose C, Rai SK, Pillinger MH, Choi HK. Contemporary prevalence of gout and hyperuricemia in the united States and decadal trends: the National health and nutrition examination Survey, 2007\u20132016. Arthritis Rheumatol. 2019;71(6):991\u20139.","journal-title":"Arthritis Rheumatol"},{"key":"2796_CR3","doi-asserted-by":"publisher","first-page":"104118","DOI":"10.1016\/j.numecd.2025.104118","volume":"8","author":"J Zhang","year":"2025","unstructured":"Zhang J, Hao Z, Ma Y, Zheng P, Huang L, Xu J, et al. Residual cholesterol is an independent risk factor for new-onset hyperuricemia: a nationwide cohort study based on a middle-aged and elderly population. Nutr Metab Cardiovasc Dis. 2025;8:104118.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2796_CR4","doi-asserted-by":"publisher","first-page":"791983","DOI":"10.3389\/fimmu.2021.791983","volume":"12","author":"M Zhang","year":"2022","unstructured":"Zhang M, Zhu X, Wu J, Huang Z, Zhao Z, Zhang X, et al. Prevalence of hyperuricemia among Chinese adults: findings from two nationally representative Cross-Sectional surveys in 2015-16 and 2018-19. Front Immunol. 2022;12:791983.","journal-title":"Front Immunol"},{"key":"2796_CR5","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1161\/CIRCULATIONAHA.106.657627","volume":"115","author":"ES Ford","year":"2007","unstructured":"Ford ES, Li C, Cook S, Choi HK. Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation. 2007;115:2526\u201332.","journal-title":"Circulation"},{"key":"2796_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13052-016-0321-0","volume":"43","author":"R Luciano","year":"2017","unstructured":"Luciano R, Shashaj B, Spreghini M, Del Fattore A, Rustico C, Wietrzykowska Sforza R, et al. Percentiles of serum uric acid and cardiometabolic abnormalities in obese Italian children and adolescents. Ital J Pediatr. 2017;43:3.","journal-title":"Ital J Pediatr"},{"key":"2796_CR7","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1080\/07853890.2022.2083670","volume":"54","author":"J Rao","year":"2022","unstructured":"Rao J, Ye P, Lu J, Chen B, Li N, Zhang H, et al. Prevalence and related factors of hyperuricaemia in Chinese children and adolescents: a pooled analysis of 11 population-based studies. Ann Med. 2022;54:1608\u201315.","journal-title":"Ann Med"},{"issue":"7","key":"2796_CR8","doi-asserted-by":"publisher","first-page":"e11578","DOI":"10.1371\/journal.pone.0011578","volume":"5","author":"C Xu","year":"2010","unstructured":"Xu C, Yu C, Xu L, Miao M, Li Y. High serum uric acid increases the risk for nonalcoholic fatty liver disease: a prospective observational study. PLoS ONE. 2010;5(7):e11578.","journal-title":"PLoS ONE"},{"issue":"1","key":"2796_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12916-017-0890-9","volume":"15","author":"T Bardin","year":"2017","unstructured":"Bardin T, Richette P. Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options. BMC Med. 2017;15(1):123.","journal-title":"BMC Med"},{"issue":"1\u20132","key":"2796_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cca.2008.02.024","volume":"392","author":"G Lippi","year":"2008","unstructured":"Lippi G, Montagnana M, Franchini M, Favaloro EJ, Targher G. The Paradoxical relationship between serum uric acid and cardiovascular disease. Clin Chim Acta. 2008;392(1\u20132):1\u20137.","journal-title":"Clin Chim Acta"},{"key":"2796_CR11","doi-asserted-by":"publisher","first-page":"102271","DOI":"10.1016\/j.redox.2022.102271","volume":"51","author":"WT Crawley","year":"2022","unstructured":"Crawley WT, Jungels CG, Stenmark KR, Fini MA. U-shaped association of uric acid to overall-cause mortality and its impact on clinical management of hyperuricemia. Redox Biol. 2022;51:102271.","journal-title":"Redox Biol"},{"issue":"1","key":"2796_CR12","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s12933-025-02803-8","volume":"24","author":"R Bergdal","year":"2025","unstructured":"Bergdal R, Harjutsalo V, Groop PH, Mutter S, FinnDiane Study Group. Cumulative exposures to glycaemia and lipids are associated with coronary artery disease in type 1 diabetes: a call for action. Cardiovasc Diabetol. 2025;24(1):248.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2796_CR13","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s13098-025-01778-6","volume":"17","author":"Q Tan","year":"2025","unstructured":"Tan Q, Nie Z, Huang Q, Zhu Y, Chen C, Feng Y. Triglyceride-glucose index and risk of abdominal aortic aneurysm: a large-scale prospective cohort study. Diabetol Metab Syndr. 2025;17(1):232.","journal-title":"Diabetol Metab Syndr"},{"key":"2796_CR14","doi-asserted-by":"publisher","first-page":"e082007","DOI":"10.1136\/bmj-2024-082007","volume":"389","author":"Z Semnani-Azad","year":"2025","unstructured":"Semnani-Azad Z, Khan TA, Chiavaroli L, Chen V, Bhatt HA, Chen A, et al. Intermittent fasting strategies and their effects on body weight and other cardiometabolic risk factors: systematic review and network meta-analysis of randomised clinical trials. BMJ. 2025;389:e082007.","journal-title":"BMJ"},{"issue":"1","key":"2796_CR15","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12902-023-01372-9","volume":"23","author":"M Zakerkish","year":"2023","unstructured":"Zakerkish M, Hoseinian A, Alipour M, Payami SP. The association between Cardio-metabolic and hepatic indices and anthropometric measures with metabolically obesity phenotypes: a cross-sectional study from the Hoveyzeh cohort study. BMC Endocr Disord. 2023;23(1):122.","journal-title":"BMC Endocr Disord"},{"issue":"1","key":"2796_CR16","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12944-018-0828-z","volume":"17","author":"TT Wu","year":"2018","unstructured":"Wu TT, Gao Y, Zheng YY, Ma YT, Xie X. Atherogenic index of plasma (AIP): a novel predictive indicator for the coronary artery disease in postmenopausal women. Lipids Health Dis. 2018;17(1):197.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"2796_CR17","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12933-025-02768-8","volume":"24","author":"X Qiu","year":"2025","unstructured":"Qiu X, Han Y, Cao C, Liao Y, Hu H. Association between atherogenicity indices and prediabetes: a 5-year retrospective cohort study in a general Chinese physical examination population. Cardiovasc Diabetol. 2025;24(1):220.","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"2796_CR18","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.jacl.2017.06.015","volume":"11","author":"ND Wong","year":"2017","unstructured":"Wong ND, Zhao Y, Quek RGW, Blumenthal RS, Budoff MJ, Cushman M, et al. Residual atherosclerotic cardiovascular disease risk in statin-treated adults: the Multi-Ethnic study of atherosclerosis. J Clin Lipidol. 2017;11(5):1223\u201333.","journal-title":"J Clin Lipidol"},{"issue":"16","key":"2796_CR19","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1093\/eurheartj\/ehac822","volume":"44","author":"BN Wadstr\u00f6m","year":"2023","unstructured":"Wadstr\u00f6m BN, Pedersen KM, Wulff AB, Nordestgaard BG. Elevated remnant cholesterol, plasma triglycerides, and cardiovascular and non-cardiovascular mortality. Eur Heart J. 2023;44(16):1432\u201345.","journal-title":"Eur Heart J"},{"issue":"11","key":"2796_CR20","first-page":"e74644","volume":"16","author":"I Raaj","year":"2024","unstructured":"Raaj I, Thalamati M, Gowda MNV, Rao A. The role of the atherogenic index of plasma and the Castelli risk index I and II in cardiovascular disease. Cureus. 2024;16(11):e74644.","journal-title":"Cureus"},{"issue":"12","key":"2796_CR21","doi-asserted-by":"publisher","first-page":"e0315396","DOI":"10.1371\/journal.pone.0315396","volume":"19","author":"X Wang","year":"2024","unstructured":"Wang X, Wu L, Shu P, Yu W, Yu W. Significant association between three atherosclerosis indexes and stroke risk. PLoS ONE. 2024;19(12):e0315396.","journal-title":"PLoS ONE"},{"issue":"1","key":"2796_CR22","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12944-025-02617-3","volume":"24","author":"W Yang","year":"2025","unstructured":"Yang W, Liu X, Wang Y, Fu Y, Ren C, Jiang A, et al. Correlation between Castelli risk index-I and female infertility: A cross-sectional study. Lipids Health Dis. 2025;24(1):200.","journal-title":"Lipids Health Dis"},{"key":"2796_CR23","doi-asserted-by":"publisher","unstructured":"Miao M, Ye C, Wang Z, Long J, You S, Sun Y et al. Traditional lipid ratios and carotid atherosclerosis in patients with ischemic stroke. Cerebrovasc Dis. 2025. https:\/\/doi.org\/10.1159\/000545676.","DOI":"10.1159\/000545676"},{"key":"2796_CR24","first-page":"8022","volume":"26","author":"XT Cai","year":"2022","unstructured":"Cai XT, Gao J, Wang MR, Liu SS, Hu JL, Hong J, Li NF. A J-shaped relationship between the atherogenic index of plasma and new-onset myocardial infarction in hypertensive patients with obstructive sleep apnea: a cohort study. Eur Rev Med Pharmacol Sci. 2022;26:8022\u20139.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2796_CR25","doi-asserted-by":"crossref","unstructured":"Wahba NS, Eleiwa NZ, Eisa NM, Ghareib SA. Telmisartan and\/or vitamin D3 ameliorate skeletal muscle injury in a rat model of metabolic syndrome: A new insight into PPAR-\u03b3\/AT1 receptor\/GLUT4 axis. Eur J Pharmacol. 2025;1002:177845.","DOI":"10.1016\/j.ejphar.2025.177845"},{"issue":"1","key":"2796_CR26","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12944-024-02171-4","volume":"23","author":"Z Wang","year":"2024","unstructured":"Wang Z, Wu M, Du R, Tang F, Xu M, Gu T, et al. The relationship between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and hyperuricaemia. Lipids Health Dis. 2024;23(1):187.","journal-title":"Lipids Health Dis"},{"key":"2796_CR27","doi-asserted-by":"publisher","first-page":"1545968","DOI":"10.3389\/fendo.2025.1545968","volume":"16","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, Zou Y, Cao Y, Gao Y, Pi Y, Tang X, et al. The association between the cardiometabolic index and hyperuricemia: 2011\u20132016 NHANES. Front Endocrinol (Lausanne). 2025;16:1545968.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10","key":"2796_CR28","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1681\/ASN.2006040368","volume":"17","author":"YC Ma","year":"2006","unstructured":"Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17(10):2937\u201344.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2796_CR29","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1161\/01.CIR.67.4.730","volume":"67","author":"WP Castelli","year":"1983","unstructured":"Castelli WP, Abbott RD, McNamara PM. Summary estimates of cholesterol used to predict coronary heart disease. Circulation. 1983;67(4):730\u20134.","journal-title":"Circulation"},{"issue":"5","key":"2796_CR30","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.arcmed.2019.08.009","volume":"50","author":"JC Fern\u00e1ndez-Mac\u00edas","year":"2019","unstructured":"Fern\u00e1ndez-Mac\u00edas JC, Ochoa-Mart\u00ednez AC, Varela-Silva JA, P\u00e9rez-Maldonado IN. Atherogenic index of plasma: novel predictive biomarker for cardiovascular illnesses. Arch Med Res. 2019;50(5):285\u201394.","journal-title":"Arch Med Res"},{"issue":"4","key":"2796_CR31","doi-asserted-by":"publisher","first-page":"194","DOI":"10.4103\/1596-3519.194280","volume":"15","author":"MA Olamoyegun","year":"2016","unstructured":"Olamoyegun MA, Oluyombo R, Asaolu SO. Evaluation of dyslipidemia, lipid ratios, and atherogenic index as cardiovascular risk factors among semi-urban dwellers in Nigeria. Ann Afr Med. 2016;15(4):194\u20139.","journal-title":"Ann Afr Med"},{"issue":"11","key":"2796_CR32","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1007\/s00380-020-01627-8","volume":"35","author":"Y Si","year":"2020","unstructured":"Si Y, Liu J, Han C, Wang R, Liu T, Sun L. The correlation of retinol-binding protein-4 and lipoprotein combine index with the prevalence and diagnosis of acute coronary syndrome. Heart Vessels. 2020;35(11):1494\u2013501.","journal-title":"Heart Vessels"},{"issue":"1","key":"2796_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5603\/cj.98254","volume":"31","author":"C Borghi","year":"2024","unstructured":"Borghi C, Domienik-Kar\u0142owicz J, Tykarski A, Filipiak KJ, Jaguszewski MJ, Narkiewicz K, et al. Expert consensus for the diagnosis and treatment of patients with hyperuricemia and high cardiovascular risk: 2023 update. Cardiol J. 2024;31(1):1\u201314.","journal-title":"Cardiol J"},{"key":"2796_CR34","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.cca.2018.05.046","volume":"484","author":"G Ndrepepa","year":"2018","unstructured":"Ndrepepa G. Uric acid and cardiovascular disease. Clin Chim Acta. 2018;484:150\u201363.","journal-title":"Clin Chim Acta"},{"issue":"7","key":"2796_CR35","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1093\/rheumatology\/kez476","volume":"59","author":"Y Xia","year":"2020","unstructured":"Xia Y, Wu Q, Wang H, Zhang S, Jiang Y, Gong T, et al. Global, regional and National burden of gout, 1990\u20132017: a systematic analysis of the global burden of disease study. Rheumatology (Oxford). 2020;59(7):1529\u201338.","journal-title":"Rheumatology (Oxford)"},{"key":"2796_CR36","doi-asserted-by":"publisher","first-page":"1424207","DOI":"10.3389\/fendo.2024.1424207","volume":"15","author":"S Song","year":"2024","unstructured":"Song S, Cai X, Hu J, Zhu Q, Shen D, Ma H, et al. Plasma aldosterone concentrations elevation in hypertensive patients: the dual impact on hyperuricemia and gout. Front Endocrinol (Lausanne). 2024;15:1424207.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2796_CR37","doi-asserted-by":"publisher","first-page":"e70122","DOI":"10.1111\/cts.70122","volume":"18","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Liu X, Luo D, Chen B, Lai C, He C, et al. Association of LDL-C\/HDL-C ratio with hyperuricemia: A National cohort study. Clin Transl Sci. 2025;18(1):e70122.","journal-title":"Clin Transl Sci"},{"issue":"13","key":"2796_CR38","doi-asserted-by":"crossref","first-page":"e41962","DOI":"10.1097\/MD.0000000000041962","volume":"104","author":"J Huang","year":"2025","unstructured":"Huang J, Chen C. The association between the ratio of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol and serum uric acid levels and risk of hyperuricemia in different sex groups: A cross-sectional study. Med (Baltim). 2025;104(13):e41962.","journal-title":"Med (Baltim)"},{"issue":"6","key":"2796_CR39","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.jacc.2023.12.002","volume":"83","author":"V Nambi","year":"2024","unstructured":"Nambi V, Abushamat LA. LDL-C Lowering in prevention of atherosclerotic cardiovascular disease: another step forward in this lifelong marathon. J Am Coll Cardiol. 2024;83(6):665\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2796_CR40","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11906-025-01336-5","volume":"27","author":"Y Ye","year":"2025","unstructured":"Ye Y, Wang J, Peng Y. Biomarkers for predicting blood pressure response to renal denervation. Curr Hypertens Rep. 2025;27(1):19.","journal-title":"Curr Hypertens Rep"},{"key":"2796_CR41","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1100\/tsw.2003.90","volume":"3","author":"T Balasubramanian","year":"2003","unstructured":"Balasubramanian T. Uric acid or 1-methyl uric acid in the urinary bladder increases serum glucose, insulin, true triglyceride, and total cholesterol levels in Wistar rats. Sci World J. 2003;3:930\u20136.","journal-title":"Sci World J"},{"issue":"1","key":"2796_CR42","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12944-019-1031-6","volume":"18","author":"YL Hou","year":"2019","unstructured":"Hou YL, Yang XL, Wang CX, Zhi LX, Yang MJ, You CG. Hypertriglyceridemia and hyperuricemia: a retrospective study of urban residents. Lipids Health Dis. 2019;18(1):81.","journal-title":"Lipids Health Dis"},{"issue":"5","key":"2796_CR43","doi-asserted-by":"publisher","first-page":"E827","DOI":"10.1152\/ajpendo.00378.2020","volume":"319","author":"M Furuhashi","year":"2020","unstructured":"Furuhashi M. New insights into purine metabolism in metabolic diseases: role of Xanthine oxidoreductase activity. Am J Physiol Endocrinol Metab. 2020;319(5):E827\u201334.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"2796_CR44","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41392-024-01916-y","volume":"9","author":"L Du","year":"2024","unstructured":"Du L, Zong Y, Li H, Wang Q, Xie L, Yang B, et al. Hyperuricemia and its related diseases: mechanisms and advances in therapy. Signal Transduct Target Ther. 2024;9(1):212.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2796_CR45","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12902-022-00937-4","volume":"22","author":"Y Al Shanableh","year":"2022","unstructured":"Al Shanableh Y, Hussein YY, Saidwali AH, Al-Mohannadi M, Aljalham B, Nurulhoque H, et al. Prevalence of asymptomatic hyperuricemia and its association with prediabetes, dyslipidemia and subclinical inflammation markers among young healthy adults in Qatar. BMC Endocr Disord. 2022;22(1):21.","journal-title":"BMC Endocr Disord"},{"issue":"2","key":"2796_CR46","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1161\/01.ATV.0000054658.91146.64","volume":"23","author":"PJ Barter","year":"2003","unstructured":"Barter PJ, Brewer HB Jr, Chapman MJ, Hennekens CH, Rader DJ, Tall AR. Cholesteryl ester transfer protein: a novel target for Raising HDL and inhibiting atherosclerosis. Arterioscler Thromb Vasc Biol. 2003;23(2):160\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"2796_CR47","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1194\/jlr.R300019-JLR200","volume":"45","author":"W Khovidhunkit","year":"2004","unstructured":"Khovidhunkit W, Kim MS, Memon RA, Shigenaga JK, Moser AH, Feingold KR, et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res. 2004;45(7):1169\u201396.","journal-title":"J Lipid Res"},{"key":"2796_CR48","doi-asserted-by":"publisher","first-page":"156941","DOI":"10.1016\/j.cyto.2025.156941","volume":"191","author":"B He","year":"2025","unstructured":"He B, Li Y, Zhou N. From genes to clinic: genomic and cross-sectional cohort analysis of oxidative stressors and lipid metabolism in European ancestry. Cytokine. 2025;191:156941.","journal-title":"Cytokine"},{"key":"2796_CR49","doi-asserted-by":"publisher","first-page":"120136","DOI":"10.1016\/j.jep.2025.120136","volume":"351","author":"P Li","year":"2025","unstructured":"Li P, Liao H, Niu Y, He X, Zhou W, Pang Z. Study on the modulation of kidney and liver function of rats with diabetic nephropathy by Huidouba through metabolomics. J Ethnopharmacol. 2025;351:120136.","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"2796_CR50","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12882-025-04113-3","volume":"26","author":"X Ma","year":"2025","unstructured":"Ma X, Guan B, Pang L. Calycosin ameliorates albuminuria in nephrotic syndrome by targeting Notch1\/Snail pathway. BMC Nephrol. 2025;26(1):198.","journal-title":"BMC Nephrol"},{"key":"2796_CR51","doi-asserted-by":"publisher","first-page":"151142","DOI":"10.1016\/j.bbrc.2024.151142","volume":"744","author":"W Zhang","year":"2025","unstructured":"Zhang W, Zhang Y, Lv W, Kong Z, Wang F, Wang Y. Isoquercitrin improves diabetes nephropathy by inhibiting the sodium-glucose co-transporter-2 pathway. Biochem Biophys Res Commun. 2025;744:151142.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"2796_CR52","doi-asserted-by":"publisher","first-page":"E512","DOI":"10.1152\/ajpendo.00399.2023","volume":"327","author":"Z Shi","year":"2024","unstructured":"Shi Z, Li X, Zhang L, Xie J, Zhong F, Guo Z, et al. Alterations of urine microRNA-7977\/G6PD level in patients with diabetic kidney disease and its association with dysfunction of albumin-induced autophagy in proximal epithelial tubular cells. Am J Physiol Endocrinol Metab. 2024;327(4):E512\u201323.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2796_CR53","doi-asserted-by":"publisher","first-page":"107387","DOI":"10.1016\/j.aquatox.2025.107387","volume":"284","author":"S Cao","year":"2025","unstructured":"Cao S, Wang X, Liu Q, Xu M, Wang Z, Jiang Y, et al. BDE-47 induces apoptosis and ferroptosis in Pseudosciaena Crocea kidney (PCK) cells by disrupting mitochondrial energy metabolism. Aquat Toxicol. 2025;284:107387.","journal-title":"Aquat Toxicol"},{"issue":"6","key":"2796_CR54","doi-asserted-by":"publisher","first-page":"167894","DOI":"10.1016\/j.bbadis.2025.167894","volume":"1871","author":"N Singh","year":"2025","unstructured":"Singh N, Kesharwani A, Sankar SHH, Gajbhiye RL, Peraman R, Bharathavikru RS, et al. Dehydrozingerone ameliorates renal structure compromised in diabetic nephropathy. Biochim Biophys Acta Mol Basis Dis. 2025;1871(6):167894.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"24","key":"2796_CR55","doi-asserted-by":"publisher","first-page":"e2505482122","DOI":"10.1073\/pnas.2505482122","volume":"122","author":"HW Kuhn","year":"2025","unstructured":"Kuhn HW, Smither MR, Jin RJ, Collins CA, Ma H, Sina J, et al. LDL receptor-mediated endocytosis of Escherichia coli \u03b1-hemolysin mediates renal epithelial toxicity. Proc Natl Acad Sci U S A. 2025;122(24):e2505482122.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2796_CR56","doi-asserted-by":"publisher","first-page":"119146","DOI":"10.1016\/j.atherosclerosis.2025.119146","volume":"403","author":"D Tramontano","year":"2025","unstructured":"Tramontano D, D\u2019Erasmo L, Larouche M, Brisson D, Lauzi\u00e8re A, Di Costanzo A, et al. The vicious circle of chronic kidney disease and hypertriglyceridemia: what is first, the Hen or the egg? Atherosclerosis. 2025;403:119146.","journal-title":"Atherosclerosis"},{"key":"2796_CR57","doi-asserted-by":"publisher","first-page":"156385","DOI":"10.1016\/j.phymed.2025.156385","volume":"138","author":"X Xu","year":"2025","unstructured":"Xu X, Shen S, Dong Y, Jiang L, Wang J, Shao Y. Protective effect of puerarin in diabetic nephropathy: A systematic review and meta-analysis of animal studies. Phytomedicine. 2025;138:156385.","journal-title":"Phytomedicine"},{"issue":"12","key":"2796_CR58","first-page":"7298","volume":"73","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Cao Y, Wang F, Wang L, Xiong L, Shen X, et al. Polysaccharide from Momordica Charantia L. Alleviates type 2 diabetes mellitus in mice by activating the IRS1\/PI3K\/Akt and AMPK signaling pathways and regulating the gut microbiota. J Agric Food Chem. 2025;73(12):7298\u2013309.","journal-title":"J Agric Food Chem"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02796-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-025-02796-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02796-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:03:12Z","timestamp":1764028992000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-025-02796-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2796"],"URL":"https:\/\/doi.org\/10.1186\/s12944-025-02796-z","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"27 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the guidelines laid out in the Declaration of Helsinki and was approved by the Medical Ethics Committee of the Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine (ethical approval number: 2023 Lunshen-KY-057).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"372"}}